dabigatran has been researched along with angiogenin in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (angiogenin) | Trials (angiogenin) | Recent Studies (post-2010) (angiogenin) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 935 | 12 | 386 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadamuro, J; Gruber, S; Haschke-Becher, E; Hoppe, UC; Jirak, P; Lichtenauer, M; Motloch, LJ; Paar, V; Prodinger, C; Wernly, B | 1 |
1 other study(ies) available for dabigatran and angiogenin
| Article | Year |
|---|---|
Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines - Slowing the vicious circle of coagulation and inflammation.
Topics: Adult; Antithrombins; Blood Coagulation; Cells, Cultured; Chemokines; Cytokines; Dabigatran; Dose-Response Relationship, Drug; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Ribonuclease, Pancreatic | 2020 |